Actions Panel
Cardiovascular Innovations 2022: The Operators Enclave TM
Cardiovascular Innovations 2022: The Operators Enclave TM
When and where
Date and time
Location
Hyatt Regency Denver 650 15th St Denver, CO 80202
Map and directions
How to get there
Refund Policy
About this event
CARDIOVASCULAR INNOVATIONS 2022: The Operators EnclaveTM
JULY 21-23, 2022
HYATT REGENCY DENVER AT COLORADO CONVENTION CENTER
Cardiovascular Innovations 2022: The Operators EnclaveTM is a world-class meeting focused on state-of-the-art therapy for peripheral, coronary, and structural heart disease. The conference features:
- Highly interactive expert discussions focused on professional experiences
- An emphasis on the latest innovations in interventional cardiovascular care
- Live case transmissions by the world's leading operators in the United States and Europe
- Satellite symposia and hands-on workshops
TARGET AUDIENCE
Cardiovascular Innovations 2022: The Operators EnclaveTM is designed to meet the needs of cardiologists, surgeons, internists, trainees, investigators, nurses, nurse practitioners, physician assistants and allied health care staff who participate in the care of patients with coronary, peripheral, and structural cardiovascular diseases. The focus of the conference is on innovative health care solutions for these patients.
ABOUT CARDIOVASCULAR INNOVATIONS FOUNDATION
Cardiovascular disease is the number one cause of death globally, accounting for nearly 17.5 million deaths each year. Cardiovascular disease may strike those in their prime years and, due to population aging, also afflict elderly people who are otherwise living healthy lives. Improvements in cardiovascular therapy have markedly reduced procedural risk, and thereby enabled the treatment of a broad range of patients, more than ever before in the history of medicine. Nonetheless, significant disparities in the delivery of cardiovascular care continue to exist, leading to large unmet clinical needs for many patients worldwide. Innovation in the delivery of cardiovascular care, as well as education of the public at-large, is essential for optimizing the management of these patients.
The Cardiovascular Innovations Foundation is organized and operated exclusively for charitable, scientific, and educational purposes within the meaning of Section 501(c)(3) of the Internal Revenue Code.
The mission of the Foundation is to address unmet needs in cardiovascular care through the study, design, and development of innovative health care solutions and education of health care providers and the larger public.
BOARD OF DIRECTORS
Subhash Banerjee, MD, FACC, FSCAI
Professor of Medicine, University of Texas Southwestern Medical Center
Chief, Division of Cardiology Director, Cardiac Catheterization Laboratory
VA North Texas Health Care System
Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FSCAI, FESC
Director, Center for Complex Coronary Interventions
Minneapolis Heart Institute at Abbott Northwestern Hospital
Mehdi H. Shishehbor, DO, MPH, PhD, FACC, FAHA, FSCAI
Professor of Medicine, CWRU
Chair, Harrington Heart & Vascular Institute
Director, Cardiovascular Interventional Center
Co-Director, Vascular Center
University Hospitals of Cleveland
Paul Sorajja, MD, FACC, FAHA, FSCAI
Director, Center for Valve and Structural Heart Disease
Minneapolis Heart Institute at Abbott Northwestern Hospital
Director, Valve Science Center
Minneapolis Heart Institute Foundation